380 related articles for article (PubMed ID: 26847183)
1. 3D Navigo™ versus TRUS-guided prostate biopsy in prostate cancer detection.
Gayet M; van der Aa A; Schmitz P; Beerlage HP; Schrier BP; Mulders PF; Mischi M; Wijkstra H
World J Urol; 2016 Sep; 34(9):1255-60. PubMed ID: 26847183
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional greyscale transrectal ultrasound-guidance and biopsy core preembedding for detection of prostate cancer: Dutch clinical cohort study.
van der Aa AAMA; Mannaerts CK; Gayet MCW; van der Linden JC; Schrier BP; Sedelaar JPM; Mischi M; Beerlage HP; Wijkstra H
BMC Urol; 2019 Apr; 19(1):23. PubMed ID: 30991993
[TBL] [Abstract][Full Text] [Related]
3. Results of a comparative analysis of magnetic resonance imaging-targeted versus three-dimensional transrectal ultrasound prostate biopsies: Size does matter.
Peltier A; Aoun F; Albisinni S; Marcelis Q; Ledinh D; Paesmans M; Lemort M; van Velthoven R
Scand J Urol; 2016 Jun; 50(3):144-8. PubMed ID: 26754860
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
5. Transrectal Ultrasound-Guided Prostate Biopsy for Cancer Detection: Performance of 2D-, 3D- and 3D-MRI Fusion Targeted Techniques.
Klein J; de Górski A; Benamran D; Vallee JP; De Perrot T; Wirth GJ; Iselin CE
Urol Int; 2017; 98(1):7-14. PubMed ID: 27784024
[TBL] [Abstract][Full Text] [Related]
6. Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: first results.
Tewes S; Hueper K; Hartung D; Imkamp F; Herrmann TR; Weidemann J; Renckly S; Kuczyk MA; Wacker F; Peters I
World J Urol; 2015 Nov; 33(11):1707-14. PubMed ID: 25774003
[TBL] [Abstract][Full Text] [Related]
7. MRI-guided biopsy of the prostate: correlation between the cancer detection rate and the number of previous negative TRUS biopsies.
Durmuş T; Reichelt U; Huppertz A; Hamm B; Beyersdorff D; Franiel T
Diagn Interv Radiol; 2013; 19(5):411-7. PubMed ID: 23886937
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging-targeted, 3D transrectal ultrasound-guided fusion biopsy for prostate cancer: Quantifying the impact of needle delivery error on diagnosis.
Martin PR; Cool DW; Romagnoli C; Fenster A; Ward AD
Med Phys; 2014 Jul; 41(7):073504. PubMed ID: 24989418
[TBL] [Abstract][Full Text] [Related]
9. Can Power Doppler enhanced transrectal ultrasound guided biopsy improve prostate cancer detection on first and repeat prostate biopsy?
Remzi M; Dobrovits M; Reissigl A; Ravery V; Waldert M; Wiunig C; Fong YK; Djavan B;
Eur Urol; 2004 Oct; 46(4):451-6. PubMed ID: 15363559
[TBL] [Abstract][Full Text] [Related]
10. Computerized transrectal ultrasound (C-TRUS) of the prostate: detection of cancer in patients with multiple negative systematic random biopsies.
Loch T
World J Urol; 2007 Aug; 25(4):375-80. PubMed ID: 17694312
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer detection by targeted prostate biopsy using the 3D Navigo system: a prospective study.
Magnier A; Nedelcu C; Chelly S; Rousselet-Chapeau MC; Azzouzi AR; Lebdai S
Abdom Radiol (NY); 2021 Sep; 46(9):4381-4387. PubMed ID: 33856508
[TBL] [Abstract][Full Text] [Related]
12. Decision analysis model comparing cost of multiparametric magnetic resonance imaging vs. repeat biopsy for detection of prostate cancer in men with prior negative findings on biopsy.
Lotan Y; Haddad AQ; Costa DN; Pedrosa I; Rofsky NM; Roehrborn CG
Urol Oncol; 2015 Jun; 33(6):266.e9-16. PubMed ID: 25858102
[TBL] [Abstract][Full Text] [Related]
13. Combined T2 and diffusion-weighted MR imaging with template prostate biopsies in men suspected with prostate cancer but negative transrectal ultrasound-guided biopsies.
Sheikh N; Wei C; Szewczyk-Bieda M; Campbell A; Memon S; Lang S; Nabi G
World J Urol; 2017 Feb; 35(2):213-220. PubMed ID: 27236302
[TBL] [Abstract][Full Text] [Related]
14. Performance of standard systematic biopsy versus MRI/TRUS fusion biopsy using the Navigo® system in contemporary cohort.
Nativ O; Shefler A; Bejar J; Peschansky S; Lavi A; Michael C; Nativ O
Urol Oncol; 2024 May; 42(5):159.e1-159.e7. PubMed ID: 38431487
[TBL] [Abstract][Full Text] [Related]
15. Cribriform morphology predicts upstaging after radical prostatectomy in patients with Gleason score 3 + 4 = 7 prostate cancer at transrectal ultrasound (TRUS)-guided needle biopsy.
Keefe DT; Schieda N; El Hallani S; Breau RH; Morash C; Robertson SJ; Mai KT; Belanger EC; Flood TA
Virchows Arch; 2015 Oct; 467(4):437-42. PubMed ID: 26229020
[TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
[TBL] [Abstract][Full Text] [Related]
17. Transrectal ultrasound-guided targeted biopsy of transition zone prostate cancer under cognitive registration with prebiopsy MRI and sonographic findings.
Won SY; Cho NH; Choi YD; Park SY
Clin Radiol; 2020 Feb; 75(2):157.e21-157.e27. PubMed ID: 31677880
[TBL] [Abstract][Full Text] [Related]
18. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
[TBL] [Abstract][Full Text] [Related]
19. 2D-3D rigid registration to compensate for prostate motion during 3D TRUS-guided biopsy.
De Silva T; Fenster A; Cool DW; Gardi L; Romagnoli C; Samarabandu J; Ward AD
Med Phys; 2013 Feb; 40(2):022904. PubMed ID: 23387775
[TBL] [Abstract][Full Text] [Related]
20. A comparison of prostate tumor targeting strategies using magnetic resonance imaging-targeted, transrectal ultrasound-guided fusion biopsy.
Martin PR; Cool DW; Fenster A; Ward AD
Med Phys; 2018 Mar; 45(3):1018-1028. PubMed ID: 29363762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
